Jung Kim

5.6k total citations · 2 hit papers
77 papers, 3.5k citations indexed

About

Jung Kim is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jung Kim has authored 77 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 20 papers in Surgery. Recurrent topics in Jung Kim's work include Prostate Cancer Treatment and Research (10 papers), Congenital Diaphragmatic Hernia Studies (9 papers) and Epigenetics and DNA Methylation (9 papers). Jung Kim is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Congenital Diaphragmatic Hernia Studies (9 papers) and Epigenetics and DNA Methylation (9 papers). Jung Kim collaborates with scholars based in United States, South Korea and Germany. Jung Kim's co-authors include Jonathan C. Zhao, Jindan Yu, Ka-wing Fong, Yeqing Angela Yang, John K. Chapin, Pamela D. Beck, Mark Laubach, Mandayam A. Srinivasan, Sean Biggs and Jerald D. Kralik and has published in prestigious journals such as Nature, JAMA and Nucleic Acids Research.

In The Last Decade

Jung Kim

73 papers receiving 3.4k citations

Hit Papers

Real-time prediction of hand trajectory by ensembles of c... 2000 2026 2008 2017 2000 2023 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung Kim United States 24 1.5k 934 869 773 633 77 3.5k
Martin Bak Denmark 32 982 0.6× 871 0.9× 733 0.8× 1.2k 1.6× 370 0.6× 91 3.3k
Gang Wu China 39 2.8k 1.8× 252 0.3× 1.2k 1.3× 815 1.1× 608 1.0× 141 4.6k
Aniruddha Chatterjee New Zealand 29 1.9k 1.2× 284 0.3× 672 0.8× 180 0.2× 210 0.3× 100 2.8k
Xiaobin Wang China 29 1.3k 0.8× 340 0.4× 830 1.0× 313 0.4× 367 0.6× 128 3.0k
Yi Zhou China 24 831 0.5× 426 0.5× 347 0.4× 355 0.5× 127 0.2× 113 2.3k
Sebastian Preißl United States 27 2.9k 1.9× 149 0.2× 428 0.5× 257 0.3× 187 0.3× 44 3.8k
Yinyan Wang China 33 662 0.4× 270 0.3× 616 0.7× 101 0.1× 700 1.1× 145 3.3k
C. Neil United States 39 3.9k 2.6× 96 0.1× 310 0.4× 401 0.5× 309 0.5× 76 5.7k
Takashi Okada Japan 41 2.9k 1.9× 234 0.3× 208 0.2× 895 1.2× 174 0.3× 213 5.3k
Hui Zong United States 26 2.1k 1.4× 59 0.1× 740 0.9× 442 0.6× 162 0.3× 93 3.8k

Countries citing papers authored by Jung Kim

Since Specialization
Citations

This map shows the geographic impact of Jung Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung Kim more than expected).

Fields of papers citing papers by Jung Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung Kim. The network helps show where Jung Kim may publish in the future.

Co-authorship network of co-authors of Jung Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Jung Kim. A scholar is included among the top collaborators of Jung Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung Kim. Jung Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richardson, Ashley, Jung Kim, Rebecca I. Torene, et al.. (2025). Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden. Arthritis & Rheumatology. 78(1). 223–230. 1 indexed citations
2.
Kim, Jung, Ammar S. Naqvi, Rebecca Kaufman, et al.. (2024). AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification. Bioinformatics. 40(3). 4 indexed citations
3.
Niewisch, Marena R., et al.. (2024). Genotype and Associated Cancer Risk in Individuals With Telomere Biology Disorders. JAMA Network Open. 7(12). e2450111–e2450111. 3 indexed citations
4.
Pemov, Alexander, Jung Kim, Wen Luo, et al.. (2024). The landscape of rare genetic variants in familial Waldenström macroglobulinemia. PubMed. 1(2). 100013–100013. 2 indexed citations
5.
Kim, Jung, Jeremy S. Haley, Uyenlinh L. Mirshahi, et al.. (2024). A genome-first approach to characterize DICER1 pathogenic variant prevalence, penetrance and cancer, thyroid, and other phenotypes in 2 population-scale cohorts. SHILAP Revista de lepidopterología. 2. 101846–101846. 2 indexed citations
6.
Ney, Gina M., Philip S. Rosenberg, Jung Kim, et al.. (2024). Cancer in Multilineage Mosaic RASopathies due to Pathogenic Variants in HRAS or KRAS : A Systematic Review and Meta-analysis. Clinical Cancer Research. 30(22). 5116–5121. 1 indexed citations
7.
Kim, Jung, David S. Dickens, Peter A. Argenta, et al.. (2023). Intronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell Tumor. JCO Precision Oncology. 7(7). e2300189–e2300189. 3 indexed citations
8.
Kim, Jung, Danielle M. Karyadi, Stephen W. Hartley, et al.. (2023). Inflated expectations: Rare-variant association analysis using public controls. PLoS ONE. 18(1). e0280951–e0280951. 2 indexed citations
9.
Haley, Jeremy S., Jung Kim, Mark Ramos, et al.. (2023). Most Fanconi anemia heterozygotes are not at increased cancer risk: A genome-first DiscovEHR cohort population study. Genetics in Medicine. 26(3). 101042–101042. 3 indexed citations
10.
Kim, Jung, Sung Kyun Lee, Nam Hoon Kim, et al.. (2022). ZnO Nanowire‐Based Early Detection of SARS‐CoV‐2 Antibody Responses in Asymptomatic Patients with COVID‐19. Advanced Materials Interfaces. 9(14). 2102046–2102046. 10 indexed citations
11.
Elbracht, Miriam, Julia Carlens, Felix Zeppernick, et al.. (2021). Unusual phenotypes in patients with a pathogenic germline variant in DICER1. Familial Cancer. 22(4). 475–480. 6 indexed citations
12.
Fong, Ka-wing, Jung Kim, Xiaodong Lü, et al.. (2021). Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer. Science Advances. 7(15). 46 indexed citations
13.
Li, Shangze, Ka-wing Fong, Galina Gritsina, et al.. (2019). Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. Cancer Research. 79(10). 2580–2592. 92 indexed citations
14.
Andrade, Kelvin C. de, Megan N. Frone, Talía Wegman-Ostrosky, et al.. (2018). Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis. Human Mutation. 40(1). 97–105. 62 indexed citations
15.
Xue, Xiangyang, Yeqing Angela Yang, Aihua Zhang, et al.. (2015). LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene. 35(21). 2746–2755. 357 indexed citations
16.
Wu, Longtao, Jonathan C. Zhao, Jung Kim, et al.. (2013). ERG Is a Critical Regulator of Wnt/LEF1 Signaling in Prostate Cancer. Cancer Research. 73(19). 6068–6079. 65 indexed citations
17.
Huncke, Tessa, et al.. (2008). The use of continuous positive airway pressure during an awake craniotomy in a patient with obstructive sleep apnea. Journal of Clinical Anesthesia. 20(4). 297–299. 18 indexed citations
18.
Kim, Jung. (2007). Virtual Environments for Medical Training. 대한기계학회 춘추학술대회. 1650–1655. 2 indexed citations
19.
Kim, Jung. (2006). Development of a Biomechanical Soft Tissue Model for a Virtual Surgery Trainer. Journal of the Korean Society for Precision Engineering. 23(2). 15–20. 3 indexed citations
20.
Lee, Sang Eun, et al.. (2004). A case of Hemolytic Disease of the Newborn due to Anti-Mi a Antibody. The Korean Journal of Blood Transfusion. 15(2). 231–235. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026